BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rorstad O. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract. J Surg Oncol. 2005;89:151-160. [PMID: 15719376 DOI: 10.1002/jso.20179] [Cited by in Crossref: 132] [Cited by in F6Publishing: 102] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Larouche V, Akirov A, Alshehri S, Ezzat S. Management of Small Bowel Neuroendocrine Tumors. Cancers (Basel) 2019;11:E1395. [PMID: 31540509 DOI: 10.3390/cancers11091395] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
2 Crosby DA, Donohoe CL, Fitzgerald L, Muldoon C, Hayes B, O'Toole D, Reynolds JV. Gastric neuroendocrine tumours. Dig Surg. 2012;29:331-348. [PMID: 23075625 DOI: 10.1159/000342988] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
3 Pedersen CK, Babu AS. Understanding the Lymphatics: Review of the N Category in the Updated TNM Staging of Cancers of the Digestive System. AJR Am J Roentgenol 2020;215:58-68. [PMID: 32432907 DOI: 10.2214/AJR.19.22636] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Walsh JC, Schaeffer DF, Kirsch R, Pollett A, Manzoni M, Riddell RH, Albarello L. Ileal “carcinoid” tumors—small size belies deadly intent: high rate of nodal metastasis in tumors ≤1 cm in size. Human Pathology 2016;56:123-7. [DOI: 10.1016/j.humpath.2016.05.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
5 Fahy BN, Tang LH, Klimstra D, Wong WD, Guillem JG, Paty PB, Temple LK, Shia J, Weiser MR. Carcinoid of the rectum risk stratification (CaRRs): a strategy for preoperative outcome assessment. Ann Surg Oncol. 2007;14:1735-1743. [PMID: 17294074 DOI: 10.1245/s10434-006-9311-6] [Cited by in Crossref: 69] [Cited by in F6Publishing: 54] [Article Influence: 4.9] [Reference Citation Analysis]
6 American Joint Committee on Cancer. Neuroendocrine Tumors. AJCC Cancer Staging Manual. New York: Springer; 2010. pp. 181-9. [DOI: 10.1007/978-0-387-88441-7_17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
7 Reynolds I, Healy P, Mcnamara DA. Malignant tumours of the small intestine. Surgeon. 2014;12:263-270. [PMID: 24637026 DOI: 10.1016/j.surge.2014.02.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
8 Young HTM, Carr NJ, Green B, Tilley C, Bhargava V, Pearce N. Accuracy of visual assessments of proliferation indices in gastroenteropancreatic neuroendocrine tumours. J Clin Pathol 2013;66:700-4. [DOI: 10.1136/jclinpath-2012-201217] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
9 Lesniak WG, Jyoti A, Mishra MK, Louissaint N, Romero R, Chugani DC, Kannan S, Kannan RM. Concurrent quantification of tryptophan and its major metabolites. Anal Biochem 2013;443:222-31. [PMID: 24036037 DOI: 10.1016/j.ab.2013.09.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
10 Ejtahed HS, Angoorani P, Soroush AR, Hasani-Ranjbar S, Siadat SD, Larijani B. Gut microbiota-derived metabolites in obesity: a systematic review.Biosci Microbiota Food Health. 2020;39:65-76. [PMID: 32775123 DOI: 10.12938/bmfh.2019-026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
11 Livoff A, Asna N, Gallego-Colon E, Daum AZ, Harkovsky T, Schaffer M. Goblet cell carcinoid of the appendix: Two case reports and a review of the literature. Mol Clin Oncol 2019;11:493-7. [PMID: 31620280 DOI: 10.3892/mco.2019.1921] [Reference Citation Analysis]
12 Stilling GA, Zhang H, Ruebel KH, Leontovich AA, Jin L, Tanizaki Y, Zhang S, Erickson LA, Hobday T, Lloyd RV. Characterization of the functional and growth properties of cell lines established from ileal and rectal carcinoid tumors. Endocr Pathol 2007;18:223-32. [PMID: 18247165 DOI: 10.1007/s12022-007-9001-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
13 Zeng Y, Lin Y, Li L, Li Y, Zhang X, Wang M, Chen Y, Luo L, Lu B, Xie Z, Liao Q. Targeted metabolomics for the quantitative measurement of 9 gut microbiota-host co-metabolites in rat serum, urine and feces by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2019;1110-1111:133-43. [PMID: 30807966 DOI: 10.1016/j.jchromb.2019.02.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Li L, Jiang L, Chen Z, Kang D, Yang Z, Liu X, Jiang W, Zhuo S, Guan G, Zhou Y, Chen J. Nonlinear optical microscopy for label-free detection of gastrointestinal neuroendocrine tumors. Lasers Med Sci 2016;31:1285-91. [PMID: 27299572 DOI: 10.1007/s10103-016-1964-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
15 Liu E, Telem DA, Warner RR, Dikman A, Divino CM. The role of Ki-67 in predicting biological behavior of goblet cell carcinoid tumor in appendix. Am J Surg. 2011;202:400-403. [PMID: 21824598 DOI: 10.1016/j.amjsurg.2010.08.036] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
16 Lionetto L, Lostia AM, Stigliano A, Cardelli P, Simmaco M. HPLC–mass spectrometry method for quantitative detection of neuroendocrine tumor markers: Vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid. Clinica Chimica Acta 2008;398:53-6. [DOI: 10.1016/j.cca.2008.08.003] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
17 Skancke M, Sharp SP, Maron DJ, Wexner SD. Elevated prevalence of nodal positivity in carcinoid tumours of the appendix smaller than 2 cm has a negative impact on overall survival. Colorectal Dis 2020;22:1958-64. [PMID: 33463877 DOI: 10.1111/codi.15287] [Reference Citation Analysis]
18 Modlin IM, Moss SF, Oberg K, Padbury R, Hicks RJ, Gustafsson BI, Wright NA, Kidd M. Gastrointestinal neuroendocrine (carcinoid) tumours: current diagnosis and management. Med J Aust 2010;193:46-52. [PMID: 20618115 DOI: 10.5694/j.1326-5377.2010.tb03742.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
19 Mantzoros I, Savvala NA, Ioannidis O, Parpoudi S, Loutzidou L, Kyriakidou D, Cheva A, Intzos V, Tsalis K. Midgut neuroendocrine tumor presenting with acute intestinal ischemia. World J Gastroenterol 2017; 23(45): 8090-8096 [PMID: 29259385 DOI: 10.3748/wjg.v23.i45.8090] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
20 Leonards LM, Pahwa A, Patel MK, Petersen J, Nguyen MJ, Jude CM. Neoplasms of the Appendix: Pictorial Review with Clinical and Pathologic Correlation. Radiographics. 2017;37:1059-1083. [PMID: 28598731 DOI: 10.1148/rg.2017160150] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
21 Bacchetti S, Pasqual EM, Bertozzi S, Londero AP, Risaliti A. Curative versus palliative surgical resection of liver metastases in patients with neuroendocrine tumors: a meta-analysis of observational studies. Gland Surg. 2014;3:243-251. [PMID: 25493256 DOI: 10.3978/j.issn.2227-684x.2014.02.05] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
22 Alekberzade AV, Krylov NN, Garmanova TN, Shahbazov R, Azari F, Zuykova KS, Litovchenko ED. [Duodenal neuroendocrine tumors]. Khirurgiia (Mosk) 2019;:87-95. [PMID: 31355821 DOI: 10.17116/hirurgia201907187] [Reference Citation Analysis]
23 Modlin IM, Moss SF, Gustafsson BI, Lawrence B, Schimmack S, Kidd M. The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant. Langenbecks Arch Surg. 2011;396:1145-1156. [PMID: 21523447 DOI: 10.1007/s00423-011-0794-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
24 Kim SJ, Kim JW, Han SW, Oh DY, Lee SH, Kim DW, Im SA, Kim TY, Seog Heo D, Bang YJ. Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy. BMC Cancer 2010;10:448. [PMID: 20731845 DOI: 10.1186/1471-2407-10-448] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
25 Ghosh J, Eglinton T, Frizelle FA, Watson AJ. Presacral tumours in adults. Surgeon. 2007;5:31-38. [PMID: 17313126 DOI: 10.1016/s1479-666x(07)80109-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
26 Brassil M, Lee R, O'Neill D, Woods G, Moloney BM, Dunne R, Morrin M, Lee MJ. Appendiceal tumours - A correlation of CT features and histopathological diagnosis. J Med Imaging Radiat Oncol 2021. [PMID: 34535980 DOI: 10.1111/1754-9485.13329] [Reference Citation Analysis]
27 Dasari A, Joish VN, Perez-olle R, Dharba S, Balaji K, Halperin DM. Work productivity burden and indirect costs associated with carcinoid syndrome diarrhea. Expert Review of Pharmacoeconomics & Outcomes Research 2020;20:507-11. [DOI: 10.1080/14737167.2019.1660646] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
28 Guglielmo FF, Wells ML, Bruining DH, Strate LL, Huete Á, Gupta A, Soto JA, Allen BC, Anderson MA, Brook OR, Gee MS, Grand DJ, Gunn ML, Khandelwal A, Park SH, Ramalingam V, Sokhandon F, Yoo DC, Fidler JL. Gastrointestinal Bleeding at CT Angiography and CT Enterography: Imaging Atlas and Glossary of Terms. Radiographics 2021;41:1632-56. [PMID: 34597220 DOI: 10.1148/rg.2021210043] [Reference Citation Analysis]
29 Benson AB 3rd, Strosberg J, Joish VN, Dharba S, Sapre D, Lapuerta P. Clinical Benefits of Telotristat Ethyl in Patients With Neuroendocrine Tumors and Low Bowel Movement Frequency: An Observational Patient-Reported Outcomes Study. Pancreas 2020;49:408-12. [PMID: 32132510 DOI: 10.1097/MPA.0000000000001496] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Bayhan Z, Yildiz YA, Akdeniz Y, Gonullu E, Altintoprak F, Mantoglu B, Capoglu R, Kahyaoglu Akkaya Z. Appendix Neuroendocrine Tumor: Retrospective Analysis of 4026 Appendectomy Patients in a Single Center. Emerg Med Int 2020;2020:4030527. [PMID: 32963833 DOI: 10.1155/2020/4030527] [Reference Citation Analysis]
31 Birkenkamp-demtröder K, Wagner L, Brandt Sørensen F, Bording Astrup L, Gartner W, Scherübl H, Heine B, Christiansen P, Ørntoft TF. Secretagogin Is a Novel Marker for Neuroendocrine Differentiation. Neuroendocrinology 2006;82:121-38. [DOI: 10.1159/000091207] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
32 Cutler HS, Ogando P, Uhr JH, Gonzalez DO, Warner RR, Divino CM. Use of Molecular Profiling to Guide Treatment Decisions in Patients with Neuroendocrine Tumors: Preliminary Results. The American Surgeon 2016;82:369-75. [DOI: 10.1177/000313481608200424] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
33 Mirakhur B, Pavel ME, Pommier RF, Fisher GA, Phan AT, Massien C, Liyanage N, Lowenthal SP, Vinik AI. Biochemical Responses in Symptomatic and Asymptomatic Patients with Neuroendocrine Tumors: Pooled Analysis of Two Phase 3 Trials. Endocrine Practice 2018;24:948-62. [DOI: 10.4158/ep-2018-0296] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Jacobs RE, Bai S, Hindman N, Shah PC. Carcinoid abdominal crisis: a case report. J Surg Oncol 2014;110:348-51. [PMID: 24860963 DOI: 10.1002/jso.23650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
35 Deng Y, Chen X, Ye Y, Shi X, Zhu K, Huang L, Zhang S, Ying M, Lin X. Histological characterisation and prognostic evaluation of 62 gastric neuroendocrine carcinomas. Contemp Oncol (Pozn) 2016;20:311-9. [PMID: 27688729 DOI: 10.5114/wo.2016.61852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
36 Leon A, Torta M, Dittadi R, Uberti ED, Ambrosio M, Fave GD, De Braud F, Tomassetti P, Gion M, Dogliotti L. Comparison between Two Methods in the Determination of Circulating Chromogranin A in Neuroendocrine Tumors (NETs): Results of a Prospective Multicenter Observational Study. Int J Biol Markers 2005;20:156-68. [DOI: 10.1177/172460080502000303] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
37 Faggiano A, Mansueto G, Ferolla P, Milone F, del Basso de Caro ML, Lombardi G, Colao A, De Rosa G. Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors. J Endocrinol Invest 2008;31:216-23. [PMID: 18401203 DOI: 10.1007/BF03345593] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
38 Modlin IM, Champaneria MC, Chan AK, Kidd M. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress. Am J Gastroenterol. 2007;102:1464-1473. [PMID: 17391319 DOI: 10.1111/j.1572-0241.2007.01185.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 92] [Article Influence: 8.3] [Reference Citation Analysis]
39 Li AF, Hsu CY, Li A, Tai LC, Liang WY, Li WY, Tsay SH, Chen JY. A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies. Cancer. 2008;112:274-283. [PMID: 18008361 DOI: 10.1002/cncr.23159] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
40 Woltering EA, Beyer DT, Thiagarajan R, Ramirez RA, Wang YZ, Ricks MJ, Boudreaux JP. Elevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the Duodenum. J Am Coll Surg 2016;222:534-42. [PMID: 26827125 DOI: 10.1016/j.jamcollsurg.2015.12.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
41 Bösch F, Bruewer K, D'Anastasi M, Ilhan H, Knoesel T, Pratschke S, Thomas M, Rentsch M, Guba M, Werner J, Angele MK. Neuroendocrine tumors of the small intestine causing a desmoplastic reaction of the mesentery are a more aggressive cohort. Surgery 2018;164:1093-9. [PMID: 30076029 DOI: 10.1016/j.surg.2018.06.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
42 Ishido K, Tanabe S, Higuchi K, Sasaki T, Katada C, Azuma M, Naruke A, Koizumi W, Mikami T. Clinicopathological evaluation of duodenal well-differentiated endocrine tumors. World J Gastroenterol 2010; 16(36): 4583-4588 [PMID: 20857530 DOI: 10.3748/wjg.v16.i36.4583] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
43 Woltering EA, Bergsland EK, Beyer DT, O’dorisio TM, Rindi G, Klimstra DS, Tang LH, Reidy-lagunes D, Strosberg JR, Wolin EM, Vinik AI, Nakakura EK, Asare EA, Bushnell DL, Schilsky RL, Wang Y, Kim MK, Liu EH, Jensen RT, Wong RKS, Ramage JK, Pommier RF. Neuroendocrine Tumors of the Appendix. In: Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR, editors. AJCC Cancer Staging Manual. Cham: Springer International Publishing; 2017. pp. 389-94. [DOI: 10.1007/978-3-319-40618-3_32] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
44 Mullen JT, Savarese DM. Carcinoid tumors of the appendix: a population-based study. J Surg Oncol. 2011;104:41-44. [PMID: 21294132 DOI: 10.1002/jso.21888] [Cited by in Crossref: 80] [Cited by in F6Publishing: 56] [Article Influence: 8.0] [Reference Citation Analysis]
45 Gustafsson BI, Kidd M, Modlin IM. Neuroendocrine tumors of the diffuse neuroendocrine system. Curr Opin Oncol. 2008;20:1-12. [PMID: 18043250 DOI: 10.1097/cco.0b013e3282f1c595] [Cited by in Crossref: 90] [Cited by in F6Publishing: 41] [Article Influence: 6.9] [Reference Citation Analysis]
46 Marcos J, Renau N, Valverde O, Aznar-laín G, Gracia-rubio I, Gonzalez-sepulveda M, Pérez-jurado LA, Ventura R, Segura J, Pozo OJ. Targeting tryptophan and tyrosine metabolism by liquid chromatography tandem mass spectrometry. Journal of Chromatography A 2016;1434:91-101. [DOI: 10.1016/j.chroma.2016.01.023] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 9.6] [Reference Citation Analysis]
47 Kim BN, Sohn DK, Hong CW, Han KS, Chang HJ, Jung KH, Lim SB, Choi HS, Jeong SY, Park JG. Atypical endoscopic features can be associated with metastasis in rectal carcinoid tumors. Surg Endosc. 2008;22:1992-1996. [PMID: 18568372 DOI: 10.1007/s00464-008-0006-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
48 Roberts J, Gonzalez RS, Revetta F, Shi C. Mesenteric tumour deposits arising from small-intestine neuroendocrine tumours are frequently associated with fibrosis and IgG4-expressing plasma cells. Histopathology 2018;73:795-800. [PMID: 29943407 DOI: 10.1111/his.13693] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
49 Lindholm EB, Lyons J, Anthony CT, Boudreaux JP, Wang Y, Woltering EA. Do Primary Neuroendocrine Tumors and Metastasis Have the Same Characteristics? Journal of Surgical Research 2012;174:200-6. [DOI: 10.1016/j.jss.2011.11.1038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
50 Strosberg JR, Benson AB, Huynh L, Duh MS, Goldman J, Sahai V, Rademaker AW, Kulke MH. Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review study. Oncologist. 2014;19:930-936. [PMID: 25096997 DOI: 10.1634/theoncologist.2014-0120] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 9.0] [Reference Citation Analysis]
51 Dasari A, Joish VN, Perez-Olle R, Dharba S, Balaji K, Halperin DM. Direct costs of carcinoid syndrome diarrhea among adults in the United States. World J Gastroenterol 2019; 25(47): 6857-6865 [PMID: 31885426 DOI: 10.3748/wjg.v25.i47.6857] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Pasqual EM, Bertozzi S, Londero AP, Bacchetti S, Lorenzin D, Pasqualucci A, Moccheggiani F, Federici A, Vivaverlli M, Risaliti A. Long term results of hepatic resection or orthotopic liver transplantation in patients with liver metastases from gastrointestinal neuroendocrine tumors. Oncol Lett 2016;12:3563-70. [PMID: 27900037 DOI: 10.3892/ol.2016.5045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
53 Patel N, Barbieri A, Gibson J. Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas.Surg Pathol Clin. 2019;12:1021-1044. [PMID: 31672292 DOI: 10.1016/j.path.2019.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
54 Valentino JD, Li J, Zaytseva YY, Mustain WC, Elliott VA, Kim JT, Harris JW, Campbell K, Weiss H, Wang C, Song J, Anthony L, Townsend CM Jr, Evers BM. Cotargeting the PI3K and RAS pathways for the treatment of neuroendocrine tumors. Clin Cancer Res 2014;20:1212-22. [PMID: 24443523 DOI: 10.1158/1078-0432.CCR-13-1897] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 5.1] [Reference Citation Analysis]
55 Turner GB, Johnston BT, McCance DR, McGinty A, Watson RG, Patterson CC, Ardill JE. Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours. Gut 2006;55:1586-91. [PMID: 16556667 DOI: 10.1136/gut.2006.092320] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 5.1] [Reference Citation Analysis]
56 Bacchetti S, Bertozzi S, Londero AP, Uzzau A, Pasqual EM. Surgical treatment and survival in patients with liver metastases from neuroendocrine tumors: a meta-analysis of observational studies. Int J Hepatol. 2013;2013:235040. [PMID: 23509630 DOI: 10.1155/2013/235040] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
57 Moreira RK, Washington K. Pathology of Gastrointestinal Neuroendocrine Tumors: An Update. Surg Pathol Clin 2010;3:327-47. [PMID: 26839134 DOI: 10.1016/j.path.2010.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
58 Matsubayashi H, Matsunaga K, Sasaki K, Yamaguchi Y, Hasuike N, Ono H. Small carcinoid tumor of papilla of the Vater with lymph node metastases. J Gastrointest Cancer 2008;39:61-5. [PMID: 19234807 DOI: 10.1007/s12029-009-9052-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
59 Kütting F, Schmidt M, Waldschmidt D, Curth H, Schramm C, Steffen HM. Neuroendocrine Carcinoma of the Gallbladder Masquerading as a Klatskin Tumor in a 74-Year-Old Male. J Gastrointest Cancer 2016;47:118-22. [PMID: 26036328 DOI: 10.1007/s12029-015-9713-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
60 Sippel RS, Chen H. Carcinoid tumors. Surg Oncol Clin N Am. 2006;15:463-478. [PMID: 16882492 DOI: 10.1016/j.soc.2006.05.002] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
61 Huynh L, Totev T, Vekeman F, Neary MP, Duh MS, Benson AB. Cost reduction from resolution/improvement of carcinoid syndrome symptoms following treatment with above-standard dose of octreotide LAR. Journal of Medical Economics 2017;20:945-51. [DOI: 10.1080/13696998.2017.1337019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
62 Kocha W, Maroun J, Kennecke H, Law C, Metrakos P, Ouellet JF, Reid R, Rowsell C, Shah A, Singh S, Van Uum S, Wong R. Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group. Curr Oncol 2010;17:49-64. [PMID: 20567626 DOI: 10.3747/co.v17i3.484] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
63 Alexiev BA, Drachenberg CB, Papadimitriou JC. Endocrine tumors of the gastrointestinal tract and pancreas: grading, tumor size and proliferation index do not predict malignant behavior. Diagn Pathol 2007;2:28. [PMID: 17686142 DOI: 10.1186/1746-1596-2-28] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
64 Burton T, Lapuerta P. Economic analysis of inadequate symptom control in carcinoid syndrome in the United States. Future Oncol. 2018;14:2361-2370. [PMID: 30095284 DOI: 10.2217/fon-2018-0129] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
65 Agostini-Vulaj D, Whitney-Miller CL, Gonzalez RS, McMahon LA, Findeis-Hosey JJ. IMP3 Immunohistochemical Expression Remains Consistent Among All Grades of Gastrointestinal Neuroendocrine Tumors. Appl Immunohistochem Mol Morphol 2018;26:288-93. [PMID: 27438513 DOI: 10.1097/PAI.0000000000000416] [Reference Citation Analysis]
66 Steffen T, Ebinger SM, Warschkow R, Lüthi C, Schmied BM, Clerici T. Long-Term Survival is not Impaired After the Complete Resection of Neuroendocrine Tumors of the Appendix. World J Surg 2015;39:2670-6. [PMID: 26223340 DOI: 10.1007/s00268-015-3164-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
67 Jensen EH, Kvols L, McLoughlin JM, Lewis JM, Alvarado MD, Yeatman T, Malafa M, Shibata D. Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors. Ann Surg Oncol. 2007;14:780-785. [PMID: 17146740 DOI: 10.1245/s10434-006-9148-z] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 3.7] [Reference Citation Analysis]
68 Valentino J, Evers BM. Recent advances in the diagnosis and treatment of gastrointestinal carcinoids. Adv Surg 2011;45:285-300. [PMID: 21954695 DOI: 10.1016/j.yasu.2011.03.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
69 Gustafsson BI, Hauso O, Drozdov I, Kidd M, Modlin IM. Carcinoid heart disease. Int J Cardiol 2008;129:318-24. [PMID: 18571250 DOI: 10.1016/j.ijcard.2008.02.019] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 5.8] [Reference Citation Analysis]
70 Khan MS, Luong TV, Watkins J, Toumpanakis C, Caplin ME, Meyer T. A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms. Br J Cancer. 2013;108:1838-1845. [PMID: 23579216 DOI: 10.1038/bjc.2013.156] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 10.4] [Reference Citation Analysis]
71 McAuliffe JC, Wolin EM. Randomized Controlled Trials in Neuroendocrine Tumors. Surg Oncol Clin N Am 2017;26:751-65. [PMID: 28923229 DOI: 10.1016/j.soc.2017.05.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
72 Landry CS, Mcmasters KM, Scoggins CR, Martin RC. Proposed Staging System for Gastrointestinal Carcinoid Tumors. The American Surgeon 2008;74:418-22. [DOI: 10.1177/000313480807400511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Tomassetti P, Campana D, Piscitelli L, Casadei R, Nori F, Brocchi E, Santini D, Pezzilli R, Corinaldesi R. Endocrine tumors of the ileum: factors correlated with survival. Neuroendocrinology. 2006;83:380-386. [PMID: 17016032 DOI: 10.1159/000096053] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
74 Frilling A, Sotiropoulos GC, Li J, Kornasiewicz O, Plöckinger U. Multimodal management of neuroendocrine liver metastases. HPB (Oxford). 2010;12:361-379. [PMID: 20662787 DOI: 10.1111/j.1477-2574.2010.00175.x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 78] [Article Influence: 9.4] [Reference Citation Analysis]
75 Malkan AD, Sandoval JA. Controversial tumors in pediatric surgical oncology. Curr Probl Surg 2014;51:478-520. [PMID: 25524425 DOI: 10.1067/j.cpsurg.2014.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
76 Strosberg J, Nasir A, Coppola D, Wick M, Kvols L. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors. Hum Pathol. 2009;40:1262-1268. [PMID: 19368957 DOI: 10.1016/j.humpath.2009.01.010] [Cited by in Crossref: 91] [Cited by in F6Publishing: 80] [Article Influence: 7.6] [Reference Citation Analysis]
77 Gonzalez RS, Liu EH, Alvarez JR, Ayers GD, Washington MK, Shi C. Should mesenteric tumor deposits be included in staging of well-differentiated small intestine neuroendocrine tumors? Mod Pathol 2014;27:1288-95. [PMID: 24457461 DOI: 10.1038/modpathol.2013.232] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
78 Wang HL, Dhall D. Goblet or signet ring cells: that is the question. Adv Anat Pathol 2009;16:247-54. [PMID: 19546612 DOI: 10.1097/PAP.0b013e3181a9d49a] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
79 Wong M, Kong A, Constantine S, Pathi R, Parrish F, Verma R, Lim C, Steer C. Radiopathological review of small bowel carcinoid tumours. Journal of Medical Imaging and Radiation Oncology 2009;53:1-12. [DOI: 10.1111/j.1754-9485.2009.02031.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
80 Rossi RE, Garcia-Hernandez J, Meyer T, Thirlwell C, Watkins J, Martin NG, Caplin ME, Toumpanakis C. Chromogranin A as a predictor of radiological disease progression in neuroendocrine tumours. Ann Transl Med. 2015;3:118. [PMID: 26207246 DOI: 10.3978/j.issn.2305-5839.2015.04.23] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
81 Cunningham JL, Grimelius L, Sundin A, Agarwal S, Janson ET. Malignant ileocaecal serotonin-producing carcinoid tumours: The presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis. Acta Oncologica 2009;46:747-56. [DOI: 10.1080/02841860701218659] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
82 Rothenstein J, Cleary SP, Pond GR, Dale D, Gallinger S, Moore MJ, Brierley J, Siu LL. Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital. Am J Clin Oncol 2008;31:64-70. [PMID: 18376230 DOI: 10.1097/COC.0b013e31807a2f49] [Cited by in Crossref: 37] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
83 Shenoy S. Primary small-bowel malignancy: update in tumor biology, markers, and management strategies. J Gastrointest Cancer. 2014;45:421-430. [PMID: 25339426 DOI: 10.1007/s12029-014-9658-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
84 Boo YJ, Park SS, Kim JH, Mok YJ, Kim SJ, Kim CS. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers. J Surg Oncol. 2007;95:110-117. [PMID: 17066436 DOI: 10.1002/jso.20616] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
85 Boškoski I, Volkanovska A, Tringali A, Bove V, Familiari P, Perri V, Costamagna G. Endoscopic resection for gastrointestinal neuroendocrine tumors. Expert Rev Gastroenterol Hepatol. 2013;7:559-569. [PMID: 23985005 DOI: 10.1586/17474124.2013.816117] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
86 Cai B, Broder MS, Chang E, Yan T, Metz DC. Predictive factors associated with carcinoid syndrome in patients with gastrointestinal neuroendocrine tumors. World J Gastroenterol 2017; 23(40): 7283-7291 [PMID: 29142475 DOI: 10.3748/wjg.v23.i40.7283] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
87 Lorenceau-Savale C, Pouzoulet J, Le Pessot F, Savoye G, Di Fiore F, Michel P, Lerebours E. Composite tumour of the oesophagus revealed by diffuse liver metastasis from its endocrine component. Dig Liver Dis 2006;38:861-2. [PMID: 16870517 DOI: 10.1016/j.dld.2006.06.001] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
88 Fahy BN, Tang LH, Klimstra D, Wong WD, Guillem JG, Paty PB, Temple LK, Shia J, Weiser MR. Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessment. Ann Surg Oncol. 2007;14:396-404. [PMID: 17094024 DOI: 10.1245/s10434-006-9197-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
89 Warner RR, Curran T, Shafir MK, Schiano TD, Khaitova V, Kim MK. Serum and ascites chromogranin-A in patients with metastatic neuroendocrine tumors. Pancreas 2011;40:622-6. [PMID: 21483253 DOI: 10.1097/MPA.0b013e3182156c0b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
90 Koc O, Duzkoylu Y, Sari YS, Bektas H, Uzum G, Tunali V, Pasaoglu E. Duodenal somatostatinoma: a case report and review of the literature. J Med Case Rep 2013;7:115. [PMID: 23618063 DOI: 10.1186/1752-1947-7-115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
91 Pinchot SN, Holen K, Sippel RS, Chen H. Carcinoid tumors. Oncologist. 2008;13:1255-1269. [PMID: 19091780 DOI: 10.1634/theoncologist.2008-0207] [Cited by in Crossref: 140] [Cited by in F6Publishing: 110] [Article Influence: 10.8] [Reference Citation Analysis]
92 Li AF, Tsay SH, Liang WY, Li WY, Chen JY. Clinical significance of p16INK4a and p53 overexpression in endocrine tumors of the gastrointestinal tract. Am J Clin Pathol 2006;126:856-65. [PMID: 17074692 DOI: 10.1309/5X6WBYJ3U94EEKNN] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
93 Pasaoglu E, Dursun N, Ozyalvacli G, Hacihasanoglu E, Behzatoglu K, Calay O. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors. Ann Diagn Pathol. 2015;19:81-87. [PMID: 25702616 DOI: 10.1016/j.anndiagpath.2015.01.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
94 Strosberg J. Neuroendocrine tumours of the small intestine. Best Pract Res Clin Gastroenterol. 2012;26:755-773. [PMID: 23582917 DOI: 10.1016/j.bpg.2012.12.002] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 6.9] [Reference Citation Analysis]
95 Patel C, Mathur M, Escarcega RO, Bove AA. Carcinoid heart disease: current understanding and future directions. Am Heart J 2014;167:789-95. [PMID: 24890526 DOI: 10.1016/j.ahj.2014.03.018] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
96 Murphy CE, McCormick KA, Shankaran V, Reddi DM, Swanson PE, Upton MP, Papanicolau-Sengos A, Khor S, Westerhoff M. Grade Assignment by Ki-67 Proliferative Index, Mitotic Count, and Phosphohistone H3 Count in Surgically Resected Gastrointestinal and Pancreatic Neuroendocrine Tumors. Pancreas 2017;46:1359-65. [PMID: 29040195 DOI: 10.1097/MPA.0000000000000923] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
97 Shi C, Woltering E, Beyer DT, Klimstra D, Mallin K, Bergsland E, Washington MK. Neuroendocrine Tumors of the Colon and Rectum. In: Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR, editors. AJCC Cancer Staging Manual. Cham: Springer International Publishing; 2017. pp. 395-406. [DOI: 10.1007/978-3-319-40618-3_33] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
98 Custodio A, Jimenez-Fonseca P, Carmona-Bayonas A, Gomez MJ, Del Olmo-García MI, Lorenzo I, Díaz JÁ, Canal N, De la Cruz G, Villabona C. Use of healthcare REsources and associated COsts in controlled versus uncontrolled carcinoid SYndrome in patients with neuroendocrine tumours: the RECOSY study. Clin Transl Oncol 2021;23:2046-56. [PMID: 34109562 DOI: 10.1007/s12094-021-02608-7] [Reference Citation Analysis]
99 Liu E, Telem DA, Hwang J, Warner RR, Dikman A, Divino CM. The clinical utility of Ki-67 in assessing tumor biology and aggressiveness in patients with appendiceal carcinoids: Assess Appendiceal Carcinoid With Ki-67. J Surg Oncol 2010;102:338-41. [DOI: 10.1002/jso.21634] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
100 Ree AH. A complex case of rectal neuroendocrine carcinoma with terminal delirium. Nat Clin Pract Gastroenterol Hepatol 2006;3:408-13; quiz 414. [PMID: 16819503 DOI: 10.1038/ncpgasthep0525] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
101 Zalom ML, Waxman AD, Yu R, Lee J, Ih G, Wolin EM. Metabolic and Receptor Imaging in Patients with Neuroendocrine Tumors: Comparison of Fludeoxyglucose-Positron Emission Tomography and Computed Tomography with Indium in 111 Pentetreotide. Endocrine Practice 2009;15:521-7. [DOI: 10.4158/ep08318.orr1] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
102 Stilo F. Gastric carcinoid tumors. J Surg Oncol 2006;93:347-9. [DOI: 10.1002/jso.20469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]